144 related articles for article (PubMed ID: 21715733)
1. A study on coverage, compliance and awareness about mass drug administration for elimination of lymphatic filariasis in a district of West Bengal, India.
Karmakar PR; Mitra K; Chatterjee A; Jana PK; Bhattacharya S; Lahiri SK
J Vector Borne Dis; 2011 Jun; 48(2):101-4. PubMed ID: 21715733
[No Abstract] [Full Text] [Related]
2. Coverage and awareness of and compliance with mass drug administration for elimination of lymphatic filariasis in Burdwan District, West Bengal, India.
Roy RN; Sarkar AP; Misra R; Chakroborty A; Mondal TK; Bag K
J Health Popul Nutr; 2013 Jun; 31(2):171-7. PubMed ID: 23930334
[TBL] [Abstract][Full Text] [Related]
3. Coverage survey for assessing mass drug administration against lymphatic filariasis in Gulbarga district, Karnataka, India.
Ranganath BG
J Vector Borne Dis; 2010 Mar; 47(1):61-4. PubMed ID: 20231778
[No Abstract] [Full Text] [Related]
4. Mass drug administration against lymphatic filariasis: experiences from Kozhikode district of Kerala State.
Regu K; Showkath Ali MK; Rajendran R; Koya SM; Ganesh B; Dhariwal AC; Lal S
J Commun Dis; 2006 Dec; 38(4):333-8. PubMed ID: 17913209
[TBL] [Abstract][Full Text] [Related]
5. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India.
Babu BV; Kar SK
Trop Med Int Health; 2004 Jun; 9(6):702-9. PubMed ID: 15189460
[TBL] [Abstract][Full Text] [Related]
6. Knowledge and perceptions about lymphatic filariasis: a study during the programme to eliminate lymphatic filariasis in an urban community of Orissa, India.
Rath K; Nath N; Shaloumy M; Swain BK; Suchismita M; Babu BV
Trop Biomed; 2006 Dec; 23(2):156-62. PubMed ID: 17322817
[TBL] [Abstract][Full Text] [Related]
7. Predictors of compliance with a mass drug administration programme for lymphatic filariasis in Orissa State, India 2008.
Cantey PT; Rao G; Rout J; Fox LM
Trop Med Int Health; 2010 Feb; 15(2):224-31. PubMed ID: 20002615
[TBL] [Abstract][Full Text] [Related]
8. Adverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India.
Babu BV; Rath K; Kerketta AS; Swain BK; Mishra S; Kar SK
Trans R Soc Trop Med Hyg; 2006 May; 100(5):464-9. PubMed ID: 16288792
[TBL] [Abstract][Full Text] [Related]
9. Mass drug administration under the programme to eliminate lymphatic filariasis in Orissa, India: a mixed-methods study to identify factors associated with compliance and non-compliance.
Babu BV; Mishra S
Trans R Soc Trop Med Hyg; 2008 Dec; 102(12):1207-13. PubMed ID: 18632125
[TBL] [Abstract][Full Text] [Related]
10. Awareness of health personnel about lymphatic filariasis and mass drug administration in Kerala State.
Showkath AM; Regu K; Rajendran R; Mohanan MK; Ganesh B
J Commun Dis; 2008 Mar; 40(1):37-40. PubMed ID: 19127667
[TBL] [Abstract][Full Text] [Related]
11. Knowledge on lymphatic filariasis and mass drug administration (MDA) programme in filaria endemic districts of Andhra Pradesh, India.
Mukhopadhyay AK; Patnaik SK; Satya Babu P; Rao KN
J Vector Borne Dis; 2008 Mar; 45(1):73-5. PubMed ID: 18399322
[No Abstract] [Full Text] [Related]
12. Mass drug administration for elimination of lymphatic filariasis: a discussion.
Wiwanitkit S; Wiwanitkit V
J Vector Borne Dis; 2011 Sep; 48(3):182; author reply 182. PubMed ID: 21946722
[No Abstract] [Full Text] [Related]
13. Using knowledge, attitudes and practice (KAP) surveys on lymphatic filariasis to prepare a health promotion campaign for mass drug administration in Alor District, Indonesia.
Krentel A; Fischer P; Manoempil P; Supali T; Servais G; Rückert P
Trop Med Int Health; 2006 Nov; 11(11):1731-40. PubMed ID: 17054754
[TBL] [Abstract][Full Text] [Related]
14. Mass drug administration to eliminate lymphatic filariasis in India.
Ramaiah KD; Das PK
Trends Parasitol; 2004 Nov; 20(11):499-502. PubMed ID: 15471698
[TBL] [Abstract][Full Text] [Related]
15. Potential factors influencing lymphatic filariasis transmission in "hotspot" and "control" areas in Ghana: the importance of vectors.
Pi-Bansa S; Osei JHN; Frempong KK; Elhassan E; Akuoko OK; Agyemang D; Ahorlu C; Appawu MA; Koudou BG; Wilson MD; de Souza DK; Dadzie SK; Utzinger J; Boakye DA
Infect Dis Poverty; 2019 Feb; 8(1):9. PubMed ID: 30717788
[TBL] [Abstract][Full Text] [Related]
16. Community-based study to assess the efficacy of DEC plus ALB against DEC alone on bancroftian filarial infection in endemic areas in Tamil Nadu, south India.
Rajendran R; Sunish IP; Mani TR; Munirathinam A; Arunachalam N; Satyanarayana K; Dash AP
Trop Med Int Health; 2006 Jun; 11(6):851-61. PubMed ID: 16772007
[TBL] [Abstract][Full Text] [Related]
17. Factors responsible for coverage and compliance in mass drug administration during the programme to eliminate lymphatic filariasis in the East Godavari District, South India.
Babu BV; Satyanarayana K
Trop Doct; 2003 Apr; 33(2):79-82. PubMed ID: 12680538
[TBL] [Abstract][Full Text] [Related]
18. Impact of mass drug administration on elimination of lymphatic filariasis in Surat city, India.
Vaishnav KG; Desai HS; Srivastava PK; Joshi PT; Kurian G; Thakor HG; Dhariwal AC
J Commun Dis; 2012 Dec; 44(4):251-9. PubMed ID: 25145075
[TBL] [Abstract][Full Text] [Related]
19. A study on coverage and compliance of mass drug administration programme for elimination of filariasis in Udupi district, Karnataka, India.
Kumar A; Kumar P; Nagaraj K; Nayak D; Ashok L; Ashok K
J Vector Borne Dis; 2009 Sep; 46(3):237-40. PubMed ID: 19724089
[No Abstract] [Full Text] [Related]
20. Use of an inclusive-partnership strategy in urban areas of Orissa, India, to increase compliance in a mass drug administration for the control of lymphatic filariasis.
Babu BV; Behera DK; Kerketta AS; Mishra S; Rath K; Swain BK; Mishra S; Kar SK
Ann Trop Med Parasitol; 2006 Oct; 100(7):621-30. PubMed ID: 16989688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
